Elopak ASA reported revenues of EUR 289.7 million in the second quarter of 2025, reflecting an organic growth of 2.4% compared to the same period last year, adjusted for currency effects. The growth was largely driven by strong performance in the Americas, supported by the continued ramp-up of the company’s new production facility in the United States.
The group reported an EBITDA margin of 15.4% for the quarter, rising slightly to 15.8% when adjusted for the start-up phase of the U.S. plant. Sales in the Americas rose by 14% on a constant currency basis, marking a key regional highlight in Elopak’s Q2 performance.
The new U.S. plant has entered commercial production, with the company aiming for full operational ramp-up by year-end. According to the company, solid cash flow throughout the quarter enabled sustained capital expenditure and dividend distribution, while maintaining a leverage ratio of 2.3x.
The Board has declared a dividend of EUR 0.03 per share for the first half of 2025. Additionally, the first installment of the 2024 dividend, amounting to EUR 0.08 per share, was paid in May.
“We are pleased with the positive result and progress we’ve made in the second quarter despite a more uncertain and challenging market environment,” said CEO Thomas Körmendi. “We continue to show resilience across key markets and expect to continue the strong performance from the first half of 2025, with full-year results in line with our mid-term targets.”
Elopak will present its Q2 2025 results on August 14, 2025, at Arctic Securities in Oslo.